Aniridia is a devastating ocular disease requiring intensive eye care, social and community support from birth and throughout an individual’s lifetime.

Recent News

© 2019 Aniridia-net.eu – University of Cologne – Webdesign by Effect Group Ltd.

About Us

COST Action CA18116

Networking to address an unmet medical, scientific, and societal challenges; Aniridia-net.eu is a pan-European network of researchers, ophthalmologist, trainees, patients organizations, industry and special interest groups funded by the European COST program to improve aniridia clinical management and promote innovative research and development of new alternatives for its diagnosis and treatment.

Action

Leadership

Positions

Neil_Lagali

Dr Neil LAGALI

Action Chair
Cursiefen_Claus

Prof Claus CURSIEFEN

Action Vice Chair
DominiqueBremond-Gignac

Prof Dominique BREMOND-GIGNAC

WG 1 Clinical Guidelines
VitoROmano

Dr Vito ROMANO

WG 2 Clinical and Cohort Studies
Stefano Ferrari

Dr Stefano FERRARI

WG 3 Stem cells and Regenerative Medicine
Davide-Borroni

Dr Davide BORRONI

WG 4 Transplantation, Inflammation and Immunity
AberdamDaniel

Prof Daniel ABERDAM

WG 5 Aniridia models for collaborative research
Christina Grupcheva

Prof Christina GRUPCHEVA

WG 6 Patient-driven research
Claus Cursiefen

Prof Claus CURSIEFEN

Grant Holder Scientific Representative
Juliana-Martinez-Atienza2

Dr Juliana MARTÍNEZ-ATIENZA

Science Communication Manager
Thomas Ritter

Prof Thomas RITTER

STSM Coordinator
SaraXapelli

Prof Sara XAPELLI

ITC Conference Manager
Rozalia Hristova

Rozaliya HRISTOVA

Training Coordinator
Augenklinik; FOR 2240

Sabrina WEBER

Administrative Coordinator

Activities

Find out all aniridia-net activities such as: Meetings, Training Schools, Short Scientific Missions, Conference Grants and Publications.

NEWS

Contact Us